MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
1-Year Return
42.84%
This Quarter Return
+10.32%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$464M
AUM Growth
-$205M
(-31%)
Cap. Flow
-$206M
Cap. Flow
% of AUM
-44.39%
Top 10 Holdings %
Top 10 Hldgs %
49.13%
Holding
326
New
128
Increased
6
Reduced
7
Closed
153
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$159M |
| 2 |
Caesars Entertainment
CZR
|
$10.4M |
| 3 |
GoodRx Holdings
GDRX
|
$8.9M |
| 4 |
Quanterix
QTRX
|
$6.58M |
| 5 |
Snowflake
SNOW
|
$6.28M |
Top Sells
| 1 |
NKLA
Nikola Corporation Common Stock
NKLA
|
$67.5M |
| 2 |
T-Mobile US
TMUS
|
$32.3M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$24.9M |
| 4 |
DraftKings
DKNG
|
$20.8M |
| 5 |
Aptiv
APTV
|
$13.2M |
Sector Composition
| 1 | Healthcare | 19.42% |
| 2 | Financials | 8.32% |
| 3 | Technology | 7.73% |
| 4 | Consumer Discretionary | 7.04% |
| 5 | Industrials | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Albertsons Companies
ACI
$10.7B
| – | – |
-400,000
| Closed | -$6.31M |
|
|
API
202
Agora
API
$310M
| – | – |
-10,000
| Closed | -$442K |
|
|
203
Aptiv
APTV
$17.5B
| – | – |
-170,000
| Closed | -$13.2M |
|
204
Arcturus Therapeutics
ARCT
$485M
| – | – |
-79,497
| Closed | -$3.72M |
|
205
argenx
ARGX
$45.9B
| – | – |
-15,000
| Closed | -$3.38M |
|
206
AST SpaceMobile
ASTS
$11.4B
| – | – |
-42,610
| Closed | -$430K |
|
207
Altice USA
ATUS
$1.05B
| – | – |
-35,000
| Closed | -$789K |
|
208
Axon Enterprise
AXON
$57.2B
| – | – |
-65,000
| Closed | -$6.38M |
|
209
BILL Holdings
BILL
$5.24B
| – | – |
-105,718
| Closed | -$9.54M |
|
|
SRTAW
210
Strata Critical Medical, Inc. Warrants
SRTAW
$2.13M
| – | – |
-35,508
| Closed | -$32K |
|
|
BLUE
211
DELISTED
bluebird bio
BLUE
| – | – |
-10,036
| Closed | -$7.94M |
|
|
BNR
212
Burning Rock Biotech
BNR
$89.4M
| – | – |
-3,000
| Closed | -$810K |
|
213
Boston Omaha
BOC
$425M
| – | – |
-40,000
| Closed | -$640K |
|
214
CareDx
CDNA
$736M
| – | – |
-70,000
| Closed | -$2.48M |
|
215
Chefs' Warehouse
CHEF
$2.61B
| – | – |
-130,000
| Closed | -$1.77M |
|
216
Celldex Therapeutics
CLDX
$1.52B
| – | – |
-300,000
| Closed | -$3.9M |
|
217
Clover Health Investments
CLOV
$1.41B
| – | – |
-249,996
| Closed | -$2.8M |
|
218
Clarivate
CLVT
$2.96B
| – | – |
-175,000
| Closed | -$3.91M |
|
219
Cannae Holdings
CNNE
$1.09B
| – | – |
-150,000
| Closed | -$6.17M |
|
220
CommScope
COMM
$3.55B
| – | – |
-200,000
| Closed | -$1.67M |
|
221
CrowdStrike
CRWD
$105B
| – | – |
-45,300
| Closed | -$4.54M |
|
222
Castle Biosciences
CSTL
$683M
| – | – |
-100,000
| Closed | -$3.77M |
|
|
223
DraftKings
DKNG
$23.1B
| – | – |
-625,000
| Closed | -$20.8M |
|
224
Dianthus Therapeutics
DNTH
$853M
| – | – |
-6,250
| Closed | -$751K |
|
225
Dynatrace
DT
$15.1B
| – | – |
-120,000
| Closed | -$4.87M |
|